Press Releases.
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
August 08, 2019Closing of First Tranche of $41.8 Million Private Placement of Equity
-
July 23, 2019Data Requirements Defined To Reinitiate Multiple Ascending Dose And Chronic Dose Studies With RGLS4326
-
June 11, 2019
-
May 09, 2019Closing of First Tranche of $41.8 Million Private Placement of Equity
-
May 06, 2019Term Loan Amended to Provide Up to Two Years of Interest Only Payments and Extension of Maturity Date to May 2022
-
May 06, 2019Up to $41.8 Million in Gross Proceeds to be Funded in Two Tranches
-
April 08, 2019Favorable Pharmacological Properties Exhibited in Preclinical Models of NASH
-
March 15, 2019
-
January 04, 2019No Adverse or Other Significant Findings to Date Across All Dose Groups Tested
-
November 19, 2018Single Dose of Lead anti-miR-10b Compound in Combination with temozolomide Resulted in over 150% Increase in Median Survival
-
November 08, 2018$47 Million Restructured Sanofi Collaboration Executed
-
November 06, 2018Sanofi Will Assume Development of RG-012 for Alport syndrome
-
October 18, 2018
-
October 04, 2018
-
September 27, 2018